Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildalip Met 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Johnlee Pharmaceuticals Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildalip Met 50/500 Tablet

Vildalip Met 50/500 tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Vildalip Met 50/500 may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose readings, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Maintaining blood sugar control prevents future complications. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle choices significantly impact blood sugar control. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; familiarity with hypoglycemia recognition and treatment is essential. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Potential drug interactions necessitate disclosure of all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its potential to lower blood glucose. Your doctor will monitor renal function and blood sugar levels throughout the treatment period.

Primary Ingredients of Vildalip Met 50/500 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Vildalip Met 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Vildalip Met 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Vildalip Met 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Vildalip Met 50/500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildalip Met 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. It's recommended to take Vildalip Met 50/500 with a meal.

How Vildalip Met 50/500 Tablet works:

Metformin and vildagliptin, combined in a 50/500 mg tablet (Vildalip Met), offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildalip Met 50/500 Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildalip Met 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildalip Met 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vildalip Met 50/500 tablets, as dosage modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver disorders should likely refrain from taking Vildalip Met 50/500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildalip Met 50/500 Tablet :

Should you forget to take a Vildalip Met 50/500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildalip Met 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildalip Met 50/500 Tablet

Vildalip Met 50/500 Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication can lead to low blood sugar. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildalip Met 50/500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always discuss taking other medications with your doctor.
Vildalip Met 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and ensure it's inaccessible to children, pets, and others.
Vildalip Met 50/500 Tablet combines metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildalip Met 50/500 Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA – Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. While rare, this risk is heightened in patients with kidney disease, the elderly, and heavy alcohol consumers. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Vildalip Met 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildalip Met 50/500 Tablet is safe when used as directed by your doctor. However, even with proper usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea) may occur. Report any persistent side effects to your doctor.
Vildalip Met 50/500 Table...
251
MRP 290
13% off